Contrast Media and the Kidney: European Society of Urogenital Radiology (ESUR) Guidelines

Overview

Journal Br J Radiol

Publisher Oxford University Press

Specialty Radiology

Date 2003 Aug 2

PMID 12893691

Citations 83

Authors

H S Thomsen

S K Morcos

Affiliations

Soon will be listed here.

Abstract

The Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) has looked at the effects of contrast media on the kidney including prevention of contrast medium induced nephropathy. This has resulted in four reports dealing with 1) contrast medium induced nephrotoxicity, 2) haemodialysis and contrast media, 3) use of gadolinium contrast media instead of iodinated contrast media and 4) contrast media injection in diabetic patients receiving metformin. The review presents an overview of these four reports and offers the current understanding of the interaction between contrast agents and the kidney.

Citing Articles

A comparison of the management and five-year outcomes of patients treated for chronic coronary syndrome between 2006-2007 and 2015-2016 - insights from the PRESAGE registry.

Kozlowska-Karaca I, Desperak P, Gasior M, Trzeciak P Cardiol J. 2024; 31(6):823-832.

PMID: 39445889 PMC: 11706261. DOI: 10.5603/cj.100464.

Berberine alleviates contrast-induced nephropathy by activating Akt/Foxo3a/Nrf2 signalling pathway.

Wang W, Yu R, Wu C, Li Q, Chen J, Xiao Y J Cell Mol Med. 2023; 28(1):e18016.

PMID: 37909687 PMC: 10805492. DOI: 10.1111/jcmm.18016.

Predictive value of CHADSVASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction.

Samir A, Gabra W, Alhossary H, Bakhoum S Egypt Heart J. 2023; 75(1):52.

PMID: 37358644 PMC: 10293538. DOI: 10.1186/s43044-023-00378-x.

Contrast Medium Use in Computed Tomography for Patients Presenting with Headache: 4-year Retrospective Two-Center Study in Central and Western Regions of Ghana.

Jimah B, Sarkodie B, Offei A, Idun E, Anim D, Brakohiapa E Radiol Res Pract. 2022; 2022:4736455.

PMID: 36248021 PMC: 9553476. DOI: 10.1155/2022/4736455.

Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.

Caracciolo A, Scalise R, Ceresa F, Bagnato G, Versace A, Licordari R J Clin Med. 2022; 11(9).

PMID: 35566504 PMC: 9100167. DOI: 10.3390/jcm11092380.